Mounjaro®
Starting from £179.99/mo
Start journey Learn moreInjecting 5mg Mounjaro follows the same technique as the 2.5mg starter dose — same KwikPen design, same injection sites, same once-weekly schedule. The pen delivers all four doses automatically; your job is site preparation and consistent timing. As a prescription-only medicine, 5mg Mounjaro is dispensed only after a prescriber has reviewed your suitability and authorised the move from 2.5mg.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
It does not. The 5mg KwikPen is mechanically identical to the 2.5mg pen, same push-button, same needle mechanism, same click to confirm delivery. The only thing that has changed is the amount of tirzepatide in each dose. People sometimes assume a higher dose needs a longer needle or a deeper injection. It does not. Mounjaro is a subcutaneous injection, meaning it goes into the fatty tissue just beneath the skin, not into muscle. The needle is short by design.
The other common worry is that 5mg will feel noticeably different to inject. In most cases it does not. Any difference in tolerability at this dose tends to be systemic (some people notice a little more nausea in the days after injecting) rather than anything to do with the injection itself. If the injection itself is uncomfortable, technique is almost always the reason: injecting too quickly, not letting the pen sit warm for a moment, or using the same site repeatedly.
The NHS tirzepatide medicines page covers the general injection method and what to do if you miss a dose. Your Patient Information Leaflet is the definitive reference for the exact steps.
Wash your hands thoroughly before you start. Take the pen from the fridge and set it on a clean surface for a few minutes, a cold pen can sting. Check the label confirms 5mg, and look through the window to make sure the liquid is clear and colourless; do not use it if it looks cloudy or contains particles.
Choose your injection site. The abdomen (keeping a few centimetres away from the navel), the outer thigh and the upper arm are all licensed sites. Rotate each week, if you used your right thigh last week, move to your abdomen or left thigh this week. Clean the skin with an alcohol swab and let it dry completely before injecting; injecting into wet skin can sting.
Remove the pen cap, press the pen flat against the skin at roughly a 90-degree angle, then push the button. Hold it there until you hear the first click and then a second click, the second click confirms the full dose has been delivered. Keep the pen against your skin for a further ten seconds before removing it. You do not need to rub the site afterwards.
Used pens are sharps and need to go into a sealed sharps bin. Your local council or pharmacy will tell you how to dispose of it. Never put a used pen in household recycling or general waste.
If you are coming to 5mg after using the 2.5mg dose from a single pen, the process of drawing two doses from one pen is explained on our page about injecting 2.5mg from a 5mg pen.
Site rotation matters more than most people expect. Repeated injections into exactly the same spot can cause lipohypertrophy (a hardening or lumpiness of the fatty tissue) which slows absorption and can make the medicine less effective over time. A simple mental map helps: divide each site area into quadrants and move around them over the weeks.
The abdomen is the easiest site for most people to reach and tends to be less sensitive than the thigh. The upper arm is convenient but usually requires someone else to help, or a degree of contortion. The outer thigh works well if you are injecting while seated. None is clinically superior to the others; comfort and consistency are what matter.
For a closer look at how the injection schedule builds from dose to dose (including what the second dose of a pen involves) our page on injecting the second Mounjaro dose covers the specifics. And if you are curious how 5mg fits into the wider treatment picture, the 5mg Mounjaro overview explains where this dose sits in the titration sequence.
Gastrointestinal effects are the most commonly reported: nausea, loose stools, constipation, indigestion. They often peak in the day or two after injecting and settle as your body adjusts. Staying well hydrated and eating smaller meals helps many people. The Mounjaro SmPC on the eMC contains the complete safety profile and is worth reading alongside your Patient Information Leaflet.
Seek medical help promptly if you develop severe, persistent stomach pain that spreads to your back, with or without vomiting. That pattern can indicate pancreatitis, which the MHRA flagged in a January 2026 Drug Safety Update as an infrequent but serious risk with GLP-1 medicines. Other signs that need prompt attention include signs of a serious allergic reaction, significant swelling at the injection site, or symptoms of dehydration from repeated vomiting or diarrhoea.
Any suspected side effect can be reported via the MHRA Yellow Card scheme, patients can do this directly, and it genuinely contributes to the safety monitoring of newer medicines like Mounjaro, which still carries a Black Triangle (▼) status.
If you have questions about what is normal at 5mg versus what needs a call to your prescriber, the team at nume's aftercare is available seven days a week. For the broader clinical picture and to understand how the 5mg dose compares with the rest of the titration schedule, the Mounjaro treatment overview is a useful starting point, and if you are also preparing a higher-strength vial, our guide on mixing 30 mg tirzepatide walks through that process in detail. And if you are still weighing up the cost of private treatment, our page on Mounjaro pricing in the UK sets out what legitimate private prescriptions typically include.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.